Alpine Global Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,678
Closed -$217K 351
2024
Q2
$217K Buy
+11,678
New +$217K 0.04% 294
2023
Q1
Sell
-3,671
Closed -$124K 321
2022
Q4
$124K Buy
+3,671
New +$124K 0.04% 132
2022
Q3
Sell
-680
Closed -$39K 487
2022
Q2
$39K Buy
+680
New +$39K 0.01% 174
2018
Q2
Sell
-1,192
Closed -$1.9M 97
2018
Q1
$1.9M Buy
+1,192
New +$1.9M 0.45% 35